Immuno-Biological Laboratories Co., Ltd. (4570.T)
JPY 458.0
(-2.35%)
JPY 458.0
(-2.35%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 235.98 Million JPY | 0.42% |
| 2022 | 234.99 Million JPY | 0.42% |
| 2021 | 233.99 Million JPY | 160.0% |
| 2020 | 90 Million JPY | -68.53% |
| 2019 | 286 Million JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 239 Million JPY | 1.28% |
| 2023 Q2 | 237.98 Million JPY | 1.71% |
| 2023 Q1 | 233.98 Million JPY | -0.43% |
| 2023 Q3 | 236.98 Million JPY | -0.42% |
| 2023 Q4 | 235.98 Million JPY | -0.42% |
| 2023 FY | 235.98 Million JPY | 0.42% |
| 2022 Q3 | 235 Million JPY | -0.84% |
| 2022 FY | 234.99 Million JPY | 0.42% |
| 2022 Q4 | 234.99 Million JPY | -0.0% |
| 2022 Q2 | 236.99 Million JPY | 0.0% |
| 2021 FY | 233.99 Million JPY | 160.0% |
| 2020 FY | 90 Million JPY | -68.53% |
| 2019 FY | - JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 2.46 Billion JPY | 90.445% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 3.69 Billion JPY | 93.621% |
| Linical Co., Ltd. | 3 Billion JPY | 92.139% |
| Trans Genic Inc. | 2.25 Billion JPY | 89.545% |
| MEDINET Co., Ltd. | 2.3 Million JPY | -10128.955% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.47 Billion JPY | 90.453% |
| AnGes, Inc. | 362.67 Million JPY | 34.933% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -120.856% |
| Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 99.681% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 78.72% |
| Carna Biosciences, Inc. | 182.97 Million JPY | -28.972% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 885.12 Million JPY | 73.339% |
| RaQualia Pharma Inc. | 367.71 Million JPY | 35.825% |
| Chiome Bioscience Inc. | 291 Million JPY | 18.907% |
| Kidswell Bio Corporation | 2.57 Billion JPY | 90.836% |
| PeptiDream Inc. | 22.79 Billion JPY | 98.965% |
| Oncolys BioPharma Inc. | 315.17 Million JPY | 25.125% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 665 Million JPY | 64.514% |
| Healios K.K. | 4.53 Billion JPY | 94.793% |
| BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | -109.762% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 142.85 Million JPY | -65.192% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 97.54 Million JPY | -141.929% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 933.3 Million JPY | 74.715% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 968 Million JPY | 75.622% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 723.93 Million JPY | 67.403% |
| StemCell Institute Inc. | 8.78 Million JPY | -2586.498% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 151.25 Million JPY | -56.021% |